18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

Pediatric Radiology

Volumn 44, Issue 3, 2014, Pages 355-361

  Piccardo, Arnoldo ^a   Lopci, Egesta ^b   Foppiani, Luca ^a   Morana, Giovanni ^c   Conte, Massimo ^c  

^a GALLIERA HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Child; Neuroblastoma; Positron emission tomography computed tomography

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DIHYDROXYPHENYLALANINE F 18; ETOPOSIDE; GD2 MONOCLONAL ANTIBODY; MELPHALAN; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; RETINOIC ACID; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

BONE MARROW NEOPLASMS; CHILD, PRESCHOOL; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; MULTIMODAL IMAGING; NEUROBLASTOMA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84899415680     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-013-2807-x     Document Type: Article

References (8)

1. Katzenstein HM, Cohn SL, Shore RM et al (2004) Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma. J Clin Oncol 22:3909-3915 (Pubitemid 41079872)
2. Matthay KK, Shulkin B, Ladenstein R et al (2010) Criteria for evaluation of disease extent by (123) I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group 16 (INRG) Task Force. Br J Cancer 102:1319-1322
3. Papathanasiou ND, Gaze MN, Sullivan K et al (2011) 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis. J Nucl Med 52:519-525
4. Jacobson AF, Deng H, Lombard J et al (2010) 123I-metaiodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 95:2596-2606
5. Matthay KK, Edeline V, Lumbroso J et al (2003) Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol 21:2486-2491 (Pubitemid 46606329)
6. Piccardo A, Lopci E, Conte M et al (2012) Comparison of (18)F-dopa PET/CT and (123)I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. Eur J Nucl Med Mol Imaging 39:57-61
7. Bonnin F, Lumbroso J, Tenenbaum F et al (1994) Refining interpretation of MIBG scans in children. J Nucl Med 35:803-810 (Pubitemid 24151215)
8. Lu MY, Liu YL, Chang HH et al (2013) Characterization of neuroblastic tumors using 18F-FDOPA PET. J Nucl Med 54:42-49